×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
FDA Enforcement Update: Advertising and Promotion
Session Chair(s)
Lucy Rose, MBA
President
Lucy Rose and Associates, United States
FDA enforcement actions and policy guidances need to be understood by every company because they reflect FDA's priorities and concerns in regulating advertising and promotion. In this forum, an FDA professional and a representative from industry will examine the latest agency enforcement actions and policies and what they mean.
Learning Objective : Describe the latest FDA enforcement actions and policy initiatives in the area of advertising and promotion; Explain what the enforcement actions reflect about FDA policies and priorities.
Speaker(s)
CDER Perspective
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
CBER Perspective
Lisa Stockbridge, PhD
FDA, United States
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
Have an account?